BioPartnering North America

BioPartnering North America

November 06, 2007 11:44 ET

BioPartnering North America Offers Innovative Partnering Opportunities for the Life Sciences-Early Registration Now Open

SANTA CRUZ, CALIFORNIA--(Marketwire - Nov. 6, 2007) - Technology Vision Group LLC (TVG) is pleased to announce that early registration is now open for the 6th Annual BioPartnering North America (BPN) conference, to be held in Vancouver, B.C., Canada, on February 3-5, 2008. Co-hosted by LifeSciences British Columbia, BIOTECanada, and BioAlberta, BPN continues to be one of the most dynamic life science conferences in North America by offering unique opportunities to meet, partner and network with leading pharmaceutical, biotechnology, financial, and service companies from around the world. Last year's conference attracted over 900 attendees from nearly 400 international life science companies and organizations from 30 countries.

Register now for BPN and save 20% off the general registration rate! http://www.techvision.com/bpn/registration/.

Apply Now for a Company Presentation at BPN

BPN offers two formats for presenting companies, each offering a unique opportunity with different focuses on stages of development and partnering goals. BPN provides biotech companies with significant opportunities to showcase their technologies and products and form valuable and meaningful business relationships.

This year there will be 22 Emerging Company presentations which feature companies from around the world that were founded in or later than 2005. Emerging companies present in a 14-minute podium presentation in the main plenary hall.

The Open House presentations will feature 56 biopharmaceutical and diagnostics companies giving interactive presentations in specially constructed booths. One of the great benefits of the Open House format is that companies are available for a 2-hour period, which allows attendees to ask the presenters detailed questions in a lively and interactive way. The Open House presentation package includes a 10-minute podium presentation, as well as other benefits. Please contact Lila Taylor at ltaylor@techvision.com for details.

Presenting opportunities will be limited to 78 companies and will fill up quickly. Applications to present can be submitted online at: http://www.techvision.com/bpn/registration/presenter/apply.php.

biopartnering.com Fosters Business Development Opportunities

BPN will once again offer attendees complimentary access to biopartnering.com, a unique and powerful internet tool and business intelligence system developed by TVG to facilitate partnering meetings. Registered attendees can utilize biopartnering.com to search for partnering opportunities through keyword searches of detailed company profiles, and to contact other attendees in advance of the event. biopartnering.com offers attendees outstanding business development tools to plan and facilitate a successful event.

"biopartnering.com is the best pharmaceutical and biotechnology partnering online tool that I have used," states Bob Seeman, CEO of Clera, Inc. of Ontario. "It is powerful and flexible and provides the information that I need to efficiently target and contact prospects that are relevant to my partnering objectives."

Leadership Sessions and Industry Workshops

BPN will also feature a full program of BioPartnering Leadership Sessions and Sponsor Workshops, offering attendees a chance to hear from leaders and decision makers in the life sciences and participate in an interactive manner. Check the conference website for the most updated program details.

Outstanding Networking Opportunities with Decision Makers

BPN annually offers outstanding networking opportunities with senior executives from the life sciences, creating an environment of business development activities focused on partnering. Numerous receptions will take place onsite, offering excellent networking opportunities to interact with the leaders and decision makers that can make the difference for your organization.

BPN is supported by leading pharmaceutical, biotechnology, financial, and service companies from around the world. Full details about BioPartnering North America can be found online at: http://www.techvision.com/bpn.

Conference Sponsors

Platinum Sponsors

AstraZeneca and Province of British Columbia

Gold Sponsors

Burrill & Company, Cooley Godward Kronish LLP, Ferghana Partners Group, and Morrison & Foerster

Silver Sponsors

Farris, Vaughan, Wills & Murphy LLP, Italian Trade Commission, Merck & Co., Inc., Pfizer Inc., PricewaterhouseCoopers, Procter & Gamble Pharmaceuticals, Roche, Seed Intellectual Property Law Group PLLC, UK Trade & Investment, and VWR International

Conference Sponsors

Anapharm, Genome British Columbia and Marsh Canada Ltd

Conference Supporters

Citigate Dewe Rogerson, MarketWire, and Washington Biotechnology & Biomedical Association (WBBA)

Media Supporters

Bio Business, BioExecutive International, Biotechnology Focus, BioWorld Today, Contact Canada®, and Nature Publishing Group

2008 Presenting Companies

Alphora Research Inc., Apthera, Inc., Aragen Bioscience, Inc., Auxilium Pharmaceuticals, Inc., Biolex Therapeutics, BioMarck Pharmaceuticals, Burnham Institute for Medical Research, Calibrant Bio, CIRION Clinical Trial Services Inc., ConjuChem, Cook Pharmica, Curalogic A/S, Cytochroma Inc., Cytokinetics, Inc., enGene Inc., ICHOR Medical Systems, ICON Clinical Research, ImmunoVaccine Technologies Inc. (IVT), Inimex Pharmaceuticals, Inc., Inovio Biomedical Corporation, ITD Hungary, Kane Biotech Inc., NeuroProtect, Inc., NPIL Torcan Chemical Ltd., Office of Biomedical Advanced Research and Development Authority (BARDA), Patheon Inc., Perceptronix Medical Inc., Pharmatek Laboratories, Inc., Pharmexa-Epimmune, Plexera Corporation, ProtAffin Biotechnologie AG, Quest PharmaTech Inc., Regeron, Inc., Scimega Research Inc., Sensific Technologies Inc., Sidec Technologies AB, Silence Therapeutics AG, SkyePharma PLC, Sloning BioTechnology GmbH, Stem Cell Therapeutics, SuperGen, Inc., Syntaxin Ltd., Thallion Pharmaceuticals, The Vaccines Company Ltd., Urigen Pharmaceuticals, Inc., Welichem Biotech Inc., XOMA LTD., YM BioSciences Inc., ZIOPHARM Oncology, Inc.

Contact Information